Aurinia Pharmaceuticals Inc.
AUPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600620
In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Aurinia Pharmaceuticals Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 189
- −8 vs. Q2 2022
- Shares held
- 55.9M
- +5.17M (+10.2%) vs. Q2 2022
- Total value
- $420.5M
- −$89.3M (−17.5%) vs. Q2 2022
- New holders
- 23
- 56 more added
- Sold out
- 31
- 54 more reduced
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AUPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 282 | $1.34B |
| Q1 2026 | 260 | $1.10B |
| Q4 2025 | 256 | $1.15B |
| Q3 2025 | 242 | $729.8M |
| Q2 2025 | 219 | $497.1M |
| Q1 2025 | 214 | $504.1M |
| Q4 2024 | 200 | $525.4M |
| Q3 2024 | 183 | $428.9M |
| Q2 2024 | 171 | $319.9M |
| Q1 2024 | 178 | $280.8M |
| Q4 2023 | 191 | $485.4M |
| Q3 2023 | 198 | $395.2M |
| Q2 2023 | 200 | $487.5M |
| Q1 2023 | 186 | $553.5M |
| Q4 2022 | 192 | $223.1M |
| Q3 2022 | 189 | $420.5M |
| Q2 2022 | 199 | $509.9M |
| Q1 2022 | 184 | $532.9M |
| Q4 2021 | 191 | $895.1M |
| Q3 2021 | 167 | $966.8M |
| Q2 2021 | 167 | $640.9M |
| Q1 2021 | 170 | $682.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aurinia Pharmaceuticals Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −32,183−100.0% | Sold out |
| Privium Fund Management (UK) Ltd | 0 | $0 | 0.00% | −29,000−100.0% | Sold out |
| Western Wealth Management, LLC | 0 | $0 | 0.00% | −26,650−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −25,187−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −22,126−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,658−100.0% | Sold out |
| Pitcairn Co | 0 | $0 | 0.00% | −19,205−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| Parametrica Management Ltd | 0 | $0 | 0.00% | −18,610−100.0% | Sold out |
| Sunbelt Securities, Inc. | 0 | $0 | 0.00% | −14,480−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −10,871−100.0% | Sold out |
| Northern Oak Wealth Management Inc | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −2,587−100.0% | Sold out |
| Worth Asset Management, LLC | 0 | $0 | 0.00% | −1,930−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,700−100.0% | Sold out |
| Selective Wealth Management, Inc. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −969−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Farmers & Merchants Investments Inc | 0 | $0 | 0.00% | −361−100.0% | Sold out |
| Sugarloaf Wealth Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Exane Derivatives | – | – | – | – | Not filed |
| Private Capital Group, LLC | – | – | – | – | Not filed |